The biotech buzz is well and truly taking over skin care – a section of the market already forecasted to hit US$8.74bn in 2025, with Proficient Market Insights projecting the global longevity biotech market to touch $22.97bn by 2034.
This momentum places beauty brands at one of the fastest developing scientific conversations of the decade – a conversation one founder has placed at the centre of her company.
For Joanna Ellner, an ex-beauty-editor-turned-accupucturist-turned-brand-founder, longevity and biotech is not seen as a passing trend, but rather a new approach entirely when it comes to skin.
“What longevity really represents is a shift in how we think about skin,” she said.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.